Vedisertib (RC48/ADC)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vedisertib (RC48/ADC), covering 2025-10-01 to 2025-10-01. Get the full timeline:
Most recent: Clinical Trial Update: Vedisertib (RC48/ADC) Combined With Toripalimab in Bladder-preserving Treatment [Phase 2]